Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.42 AUD | +0.47% | +2.79% | +0.95% |
Apr. 15 | Ansell Launches AU$65 Million Share Purchase Plan | MT |
Apr. 10 | JPMorgan Upgrades Ansell to Overweight from Neutral, Price Target is AU$29.20 | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company benefits from high valuations in earnings multiples.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.95% | 2.33B | B | ||
-2.80% | 187B | C+ | ||
-1.87% | 106B | C | ||
-4.45% | 66.9B | A | ||
+0.61% | 49.45B | B- | ||
+16.69% | 48B | B- | ||
+4.06% | 40.84B | B+ | ||
+3.61% | 26.48B | B | ||
+1.01% | 26.25B | A- | ||
+12.96% | 24.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ANN Stock
- Ratings Ansell Limited